Time for a pop quiz

 - 
11/29/2012

In honor of 1.) the 2011 data finally being added to our HME Databank (thank you for your patience!) and 2.) the 2012 State of the Industry Report appearing in our December issue, I have a little pop quiz for you.

HME Databank

1.)    Who were the top five providers of CPAP devices (E0601) in 2011?
2.)    Who was the No. 1 provider of blood glucose strips in New York?
3.)    How much did Medicare spend on oxygen concentrators (E1390) in 2011?
4.)    How much did Medicare spend on oxygen concentrators in Allegheny County in Pennsylvania, a Round 1 competitive bidding area, in 2011?
5.)    How much did Medicare spend on oxygen concentrators in Allegheny County in Pennsylvania in 2010?

2012 State of the Industry Report

1.)    How many DMEPOS providers billed Medicare more than $10 million per year in 2011?
2.)    Which product in the respiratory category experienced the most growth in utilization in 2011?
3.)    Which product in the DME category experienced the least growth in utilization in 2011?
4.)    Where did the national providers rank in 2011?
5.)    Who is Zoll Lifecor Corp., ranked 28 on the top providers list?

You can sign up for the HME Databank at www.hmedatabank.com, and you can download the 2012 State of the Industry Report from the resources page on our web site (it’s the third report listed).

Happy data crunching.

Answers

1.)    Apria (about $6.6 million in Medicare reimbursement), Lincare (about $4.8 million), Braden Partners (about $3.2 million), American HomePatient (about $1.5 million), Sleepmed Therapies (about $888,000)
2.)    Oxford Diabetic Supply (about $2.3 million)
3.)    About $1.4 billion
4.)    About $2.2 million
5.)    About $4.2 million

1.)    69
2.)    Replacement nasal cushion (A7032), up about 30%
3.)    Powered pressure reducing air mattress (E0277), down about 21%
4.)    Lincare: 1; Apria Healthcare: 2; American HomePatient: 14; and Rotech: 86
5.)    Zoll Lifecor Corp. develops wearable defibrillators for persons with SCA/SCD risk in the United States and Europe. It offers LifeVest wearable cardioverter defibrillator, which is worn outside the body to monitor the patient's heart with non-adhesive sensing electrodes to detect life-threatening abnormal heart rhythms and alert the conscious patient if a life-threatening rhythm is detected, as well as release a gel over the therapy electrodes and deliver an electrical shock to restore normal rhythm when the patient is unconscious.